Filing Details
- Accession Number:
- 0001209191-20-057330
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 17:38:48
- Reporting Period:
- 2020-11-04
- Accepted Time:
- 2020-11-06 17:38:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1647234 | Mostafa Kamal | 4801 East Washington Street Phoenix AZ 85034 | Ceo, Magellan Rx Management | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2020-11-04 | 3,434 | $64.87 | 9,051 | No | 4 | X | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Disposition | 2020-11-04 | 3,434 | $79.89 | 5,617 | No | 4 | S | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2020-11-05 | 3,589 | $64.87 | 9,206 | No | 4 | X | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Disposition | 2020-11-05 | 3,589 | $79.87 | 5,617 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-04 | 3,434 | $0.00 | 3,434 | $64.87 |
| Common Stock | Stock Options (right to buy) | Disposition | 2020-11-05 | 3,589 | $0.00 | 3,589 | $64.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,589 | 2026-03-03 | No | 4 | X | Direct | |
| 0 | 2026-03-03 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $79.8925. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- All of the stock options in this tranche have vested in full.
- Not applicable.
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
Billionaire Hedge Funds
